Mark Boyer

Mark Boyer currently serves as the Principal IDEAtor - Commercial at IDEA Pharma since February 2019, focusing on unlocking the potential of pharmaceutical molecules. Prior to this role, Mark operated as an independent marketing consultant in the healthcare sector and held significant positions at Health Management Resources and Merck, where responsibilities included directing strategy and new business development. Mark's background also features leadership roles in marketing and business development at various organizations, including Shire and AstraZeneca, where contributions included creating strategic marketing functions and managing large budgets. Mark holds multiple degrees, including an MBA in Finance from The Wharton School, a BA in Biology from Bethel University, and an MSc in Molecular Biology from Northwestern University.